Immunotherapy of cancer
Invited discussant abstracts 1047O and 1048O
Date
07 Oct 2016Session
Immunotherapy of cancerPresenters
Inge-Marie SvaneAuthors
I. SvaneAuthor affiliations
- Herlev and Gentofte Hospital, 2730 - Herlev/DK
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
3148 - A first-in-human (FIH) study of PF-04518600 (PF-8600) OX40 agonist in adult patients (pts) with select advanced malignancies
Presenter: Adi Diab
Session: Immunotherapy of cancer
Resources:
Abstract
3680 - Phase I/II CANON study: oncolytic immunotherapy for the treatment of non-muscle invasive bladder (NMIBC) cancer using intravesical coxsackievirus A21
Presenter: Hardev Pandha
Session: Immunotherapy of cancer
Resources:
Abstract
1584 - Preventive dendritic cell vaccination in healthy Lynch syndrome mutation carriers
Presenter: Harm Westdorp
Session: Immunotherapy of cancer
Resources:
Abstract
Invited discussant abstracts 1052PD, 1053PD, 1054PD and 1056PD
Presenter: Suzy Scholl
Session: Immunotherapy of cancer
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.